ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Komen Foundation Awards New Grants

October 20, 1995

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

ACCC Workshop Set for Sept; Planning Grant Okd

June 6, 1975

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

NIH To Fund Fewer Grants This Year, But Reduce Cuts to Individual Awards.

February 8, 2008